|
|
|
|
|
|
Atyr Pharma Inc (LIFE)
|
|
3.90 +0.05 (+1.30%)
|
9/20/2017 4:00pm
|
|
Open:
|
3.80
|
Pre. Close:
|
3.85
|
|
High:
|
4.05
|
Low:
|
3.75
|
|
Volume:
|
225,869
|
Market Cap:
|
92.97M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
4.19 - 4.2
|
4.2 - 4.23
|
|
Low:
|
3.52 - 3.57
|
3.57 - 3.71
|
|
Close:
|
3.76 - 3.82
|
3.82 - 4.01
|
|
|
|
|
|
|
Technical analysis (as of: 2017-09-20 4:39:56 PM)
|
|
Overall:
|
 
|
|
Stoxline posted a BUY today, upgraded from lower rating. This stock seems to be ready for a new bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, a new upward move is expected.
|
|
Target:
|
Six months: 4.73 One year: 5.53
|
|
Support:
|
Support1: 2.97 Support2: 2.30
|
|
Resistance:
|
Resistance1:
4.05 Resistance2: 4.73
|
|
Pivot:
|
3.25
|
|
Moving Averages:
|
MA(5): 3.72 MA(20): 3.10
MA(100): 3.27 MA(250): 3.18
|
|
MACD:
|
MACD(12,26):
0.20 Signal(12,26,9): 0.08
|
|
%K %D:
|
%K(14,3): 94.56  %D(3): 95.47
|
|
RSI:
|
RSI(14): 71.16
|
|
52-Week:
|
High: 4.45
Low: 2.10 Change(%): 17.1
|
|
Average Vol(K):
|
3-Month: 4207
10-Days 4635
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.LIFE has closed below upper band by 6.9%. Bollinger Bands are 143.8% wider than normal. The large width of the bands suggest high volatility as compared to LIFE's normal range. The bands have been in this wide range for 8 bars. This is a sign that the current trend might continue.
|
|
|
Headline News
|
|
Wed, 06 Sep 2017 03:00:00 GMT
aTyr Pharma to Present at Two Upcoming Investor Conferences in September
Thu, 06 Oct 2016 13:04:16 GMT
aTyr Pharma Presents Additional Data for Resolaris™ Phase 1b/2 Trial in Adult ...
Thu, 16 Mar 2017 20:08:24 GMT
aTyr Pharma Announces Fourth Quarter and Year-End 2016 Operating Results
Fri, 09 Dec 2016 14:14:00 GMT
aTyr Pharma to Present at the BMO Prescriptions for Success Healthcare Conference
Mon, 14 Aug 2017 20:03:45 GMT
aTyr Pharma Announces Second Quarter 2017 Operating Results and Provides an ...
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
NA
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
